It does.
More arms being hit in the clinic next year with new trials. Will this be the catalyst to move the price.
Market cap seems very undervalued considering pipeline potential. But the market knows best.
Patience needed with this one, but I think it will be worth it.
Add to My Watchlist
What is My Watchlist?